A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma.
Thomas G. Martin
No relevant relationships to disclose
Karl Hsu
Employment or Leadership Position - Sanofi
Eric Charpentier
Employment or Leadership Position - Sanofi
Ravi Vij
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Onyx
Honoraria - Celgene; Millennium; Onyx
Research Funding - Celgene; Onyx
Rachid C. Baz
Research Funding - Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Millennium; Novartis; Sanofi
Don M. Benson
No relevant relationships to disclose
Nikoletta Lendvai
No relevant relationships to disclose